Combination treatment with intrahepatic arterial infusion and intratumoral injection chemotherapy in patients with far-advanced hepatocellular carcinoma and arterioportal or arteriovenous shunts: preliminary results
Ja Seon Kim, Young Min Park, Nha Young Kim, Han Kyeol Yun, Ki Jong Lee, Bo Hyun Kim, Sang Jong Park, Jae Woo Yeon, Guhung Jung
Korean J Hepatol. 2011;17(2):120-129.   Published online 2011 Jun 23     DOI: https://doi.org/10.3350/kjhep.2011.17.2.120
Citations to this article as recorded by Crossref logo
Cancer Cell Resistance to IFNγ Can Occur via Enhanced Double-Strand Break Repair Pathway Activity
Tong Han, Xujun Wang, Sailing Shi, Wubing Zhang, Jue Wang, Qiu Wu, Ziyi Li, Jingxin Fu, Rongbin Zheng, Jiamin Zhang, Qin Tang, Peng Zhang, Chenfei Wang
Cancer Immunology Research.2023; 11(3): 381.     CrossRef
diTFPP, a Phenoxyphenol, Sensitizes Hepatocellular Carcinoma Cells to C2-Ceramide-Induced Autophagic Stress by Increasing Oxidative Stress and ER Stress Accompanied by LAMP2 Hypoglycosylation
Chien-Chih Chiu, Yen-Chun Chen, Yung-Ding Bow, Jeff Yi-Fu Chen, Wangta Liu, Jau-Ling Huang, En-De Shu, Yen-Ni Teng, Chang-Yi Wu, Wen-Tsan Chang
Cancers.2022; 14(10): 2528.     CrossRef
Fluoropyrimidine Modulation of the Anti-Tumor Immune Response―Prospects for Improved Colorectal Cancer Treatment
William H. Gmeiner
Cancers.2020; 12(6): 1641.     CrossRef
Interferon-Gamma at the Crossroads of Tumor Immune Surveillance or Evasion
Flávia Castro, Ana Patrícia Cardoso, Raquel Madeira Gonçalves, Karine Serre, Maria José Oliveira
Frontiers in Immunology.2018;[Epub]     CrossRef
Dendrimer-doxorubicin conjugates exhibit improved anticancer activity and reduce doxorubicin-induced cardiotoxicity in a murine hepatocellular carcinoma model
Sibu P. Kuruvilla, Gopinath Tiruchinapally, A. Colleen Crouch, Mohamed E. H. ElSayed, Joan M. Greve, Nicola Amodio
PLOS ONE.2017; 12(8): e0181944.     CrossRef